| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $142.2M | — | -14.5% |
| Cost of Revenue | $36.1M | — | -5.3% |
| Gross Profit | $106.1M | — | -17.2% |
| R&D Expense | $35.2M | — | +1.0% |
| SG&A Expense | $20.0M | — | +17.7% |
| Operating Income | $42.8M | — | -38.6% |
| Pre-tax Income | $45.3M | — | -43.5% |
| Income Tax | $9.4M | — | -40.0% |
| Net Income | $35.9M | — | -44.3% |
| EPS (Basic) | $0.76 | — | -43.7% |
| EPS (Diluted) | $0.76 | — | -43.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $159.4M | +15.2% | +1.2% |
| Short-term Investments | $357.1M | -23.0% | -13.7% |
| Accounts Receivable | $93.6M | -21.9% | -32.9% |
| Inventory | $248.2M | +3.0% | +25.7% |
| Current Assets | $932.3M | -14.2% | -8.5% |
| Total Assets | $1.89B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $108.9M | — | +256.2% |
| Capital Expenditures | $8.6M | — | -34.1% |
| Investing Cash Flow | $9.9M | — | -83.0% |
| Financing Cash Flow | -$97.7M | — | -223.3% |
| Free Cash Flow | $100.3M | — | +472.9% |
| +1.6% |
| Current Liabilities | $97.8M | -9.5% | -13.6% |
| Total Liabilities | $190.7M | -5.9% | -7.0% |
| Stockholders' Equity | $1.70B | -3.2% | +2.7% |